TTR and amyloidosis: In addition, recent in vitro studies have revealed that TG68 holds promise for neuroprotection and displays a remarkable ability to stimulate oligodendrocytes (OPC) differentiation and overcome inflammation-mediated pathological conditions [31], as well as to potently inhibit transthyretin (TTR)-mediated amyloidosis (TTRA) [32].